// App-Quantinova.ai

P374 : BLINATUMOMAB AS CONSOLIDATION FOR ADULT B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA. A REAL-WORLD STUDY

Researchers

Presenter

  • Irene Urbino

Principal Investigators

  • Etienne Lengline

  • Marco Cerrano

  • Florence Rabian

  • Rathana Kim

  • Marie Sebert

  • Raphael Itzykson

  • Ernesta Audisio

  • Lionel Ades

  • Herv Dombret

  • Emmanuel Raffoux

  • Dario Ferrero

  • Emmanuelle Clappier

  • Nicolas Boissel

Medical Centers

  • Hematology Laboratory,Saint-Louis Hospital - Université de Paris,Paris,Francia

  • Hematology Laboratory,Saint-Louis Hospital - Université de Paris,Paris,Francia

  • Hematology Laboratory,Saint-Louis Hospital - Université de Paris,Paris,Francia

  • Hematology Laboratory,Saint-Louis Hospital - Université de Paris,Paris,Francia

  • Hematology Laboratory,Saint-Louis Hospital - Université de Paris,Paris,Francia

  • Department of Molecular Biotechnology and Health

  • Hematology Laboratory,Saint-Louis Hospital - Université de Paris,Paris,Francia

  • Hematology Department,AOU Città della Salute e della Scienza

  • Patology Unit,AOU Città della Salute e della Scienza, Torino, Italy,Torino,Italy

  • Department of Molecular Biotechnologies and Health Sciences, Hematology Division, University of Torino, Torino, Italy

  • Department of Molecular Biotechnologies and Health Sciences, Hematology Division, University of Torino, Torino, Italy

  • Hemat

  • Department of Molecular Biotechnologies and Health Sciences, Hematology Division, University of Torino, Torino, Italy

Locations

  • Italy

  • France

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • B-cell acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • Blinatumomab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved